Hydrochloric acid salt of a 5-ht2c agonist
TW202629150APending Publication Date: 2026-07-16ARENA PHARMACEUTICALS INC
Patent Information
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- ARENA PHARMACEUTICALS INC
- Filing Date
- 2025-09-30
- Publication Date
- 2026-07-16
Smart Images

Figure 00000000_0000_ABST
Abstract
A crystalline (R)-N-(2,2-difluoroethyl)-7-methyl-1,2,3,4,6,7-hexahydro-[1,4]diazapolo[6,7,1-hi]indole-8-methamide (compound 1) hydrochloric acid (HCl) salt is provided. Pharmaceutical compositions comprising this salt and methods of use thereof are also provided. Provided is crystalline (R)-N-(2,2-difluoroethyl)-7-methyl-l,2,3,4,6,7-hexahydro-[l,4]diazepino[6,7,l-hi]indole-8-carboxamide (Compound 1) hydrochloric acid (HCl) salt. Also provided pharmaceutical compositions comprising the salt form and methods for its use.
Need to check novelty before this filing date? Find Prior Art